Medical Cannabis Advocacy in South Asia During the 1930s

Context: The 1894 Report Casts a Long Shadow

By the 1930s, cannabis had been used medicinally across South Asia for centuries in Ayurvedic, Unani, and folk traditions, and had also entered Western medicine through William O'Shaughnessy's 1839 Calcutta experiments ^[1]. The dominant reference point for any 1930s policy discussion was the seven-volume Indian Hemp Drugs Commission Report of 1894, which had concluded that moderate use of cannabis caused no significant physical, mental, or moral harm and that prohibition would be unjustifiable and unenforceable ^[2] Strong evidence.

That report shaped the Government of India's posture through the interwar period. Cannabis (as ganja, charas, and bhang) remained legally available under a provincial excise system, and Indian physicians continued to prescribe cannabis tinctures and extracts listed in the Pharmacopoeia of India.

The Geneva Battles, 1924–1935

The pivotal fights happened not in Delhi but in Geneva. At the Second Opium Conference (1924–1925), the Egyptian delegate Mohamed El Guindy pushed to add cannabis (specifically hashish) to international drug control. India's delegate, Sir Malcolm Delevingne's colleague John Campbell, resisted, arguing that cannabis had legitimate religious and medicinal use in India and that any restriction should exempt these uses ^[3] Strong evidence.

The compromise: the 1925 Geneva Convention placed Indian hemp under international control for export purposes but left domestic use to member states. India retained the ability to license medical and quasi-medical use ^[3].

Throughout the 1930s, the League of Nations Advisory Committee on Traffic in Opium and Other Dangerous Drugs continued to press for tighter cannabis controls. India's representatives repeatedly cited the 1894 Commission and submitted annual reports defending the domestic excise system as a regulated middle path between prohibition and free trade ^[4].

Domestic Voices: Physicians and Vaidyas

Within India, advocacy was fragmented. The Indian Medical Service, staffed largely by British-trained physicians, maintained cannabis preparations (tincture of cannabis, extractum cannabis indicae) in official formularies well into the 1930s ^[5]. Ayurvedic and Unani practitioners defended vijaya (a Sanskrit name for cannabis) and bhang as traditional remedies for digestive complaints, sleep, and pain [evidence:weak — most surviving documentation is from practitioner texts rather than controlled studies].

However, there was no organized 'cannabis advocacy movement' in the modern sense. What existed was:

• Provincial excise departments defending revenue
• Individual physicians publishing case reports in journals like the Indian Medical Gazette ^[6]
• Ayurvedic revivalist movements incorporating cannabis into broader arguments for indigenous medicine
• Religious communities (particularly some Shaiva and Sufi orders) defending ritual use

Calling this collective activity 'advocacy' overstates its coordination.

The Revenue Question

A point often omitted in romantic retellings: much of the colonial government's defense of cannabis was financial. Provincial governments in Bengal, the United Provinces, and Bombay collected substantial excise revenue from licensed ganja and bhang shops. Internal Government of India correspondence from the 1930s repeatedly weighed prohibition against revenue loss ^[4] Strong evidence.

This is not to say medical arguments were insincere — they weren't — but the coalition defending cannabis included excise officials whose primary concern was fiscal, not therapeutic.

How Myths Developed

Several popular narratives about 1930s South Asian cannabis advocacy don't hold up well:

Myth: India single-handedly kept cannabis legal at the League of Nations. Reality: India argued for exemptions and won partial ones, but the trajectory was toward greater control. India was one voice among many, and by the 1961 Single Convention its position had substantially eroded Disputed.

Myth: The 1894 Commission was re-endorsed in the 1930s. Reality: The Commission was cited, but no new comprehensive review was undertaken. The 1930s position was essentially defensive citation of a 40-year-old document Strong evidence.

Myth: Ayurvedic physicians led an organized defense of cannabis. Reality: Ayurvedic revivalism was real but cannabis was a minor part of it; the loudest defenders were colonial excise officials and Indian Medical Service pharmacists Weak / limited.

Myth: Gandhi supported medical cannabis. No credible primary source supports this. Gandhi's views on intoxicants were generally restrictive, and this claim appears to be modern invention No data.

Legacy

By the end of the decade, cannabis remained legally available in India under provincial excise regimes, and tincture of cannabis was still in Indian and British pharmacopoeias. But international momentum toward prohibition was clear. The 1930s advocacy delayed rather than prevented the eventual criminalization that came with India's Narcotic Drugs and Psychotropic Substances Act of 1985, which finally implemented the 1961 Single Convention's cannabis provisions domestically ^[7].

For modern readers, the 1930s South Asian experience is a useful counterpoint to the American prohibition story: it shows that even with a large, well-documented tradition of medical and cultural use, and even with government officials willing to defend that use, the international prohibition regime advanced. Evidence and tradition were not enough.

Sources

How this page was made